NFKB1 and oral mucositis: By reducing the expression of the NFKB/P65 gene and protein, these compounds reduce the levels of anti-inflammatory cytokines such as TNF-a and IL-6, and by the same mechanism, they can reduce ulcers and inflammation in oral mucositis (12).